Examining Challenges with Drug Switching and Step Therapy in MS Treatment

Video content above is prompted by the following questions:

• Do you ever encounter challenges with step therapy requirements after initially selecting a drug class?
• What patient factors do you consider when deciding to switch a patient to a different therapy in patients diagnosed with non-relapsing secondary progressive multiple sclerosis?
• Are step therapies typically used for drugs within the same class, or do payers typically use step therapy between different classes of drugs?